Individualisation of the Dose of Letrozole for Ovulation Induction in Infertile Women with Polycystic Ovary Syndrome Based on Clinical and Ultrasonography Criteria: A Cohort Study

Background: Conventionally, letrozole for ovulation induction (OI) in polycystic ovary syndrome (PCOS) is started at a dose of 2.5 mg, which is gradually escalated depending on the follicular response. The minimum dose required for follicular response for a particular patient is yet to be determined...

Full description

Saved in:
Bibliographic Details
Main Authors: Pratyasha Peepal, Padmalaya Thakur, Anubhuti Patel, Jyotiranjan Sahoo, Sujata Pradhan, Manisha Sahu
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2025-04-01
Series:Journal of Human Reproductive Sciences
Subjects:
Online Access:https://journals.lww.com/10.4103/jhrs.jhrs_72_25
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1839639504536731648
author Pratyasha Peepal
Padmalaya Thakur
Anubhuti Patel
Jyotiranjan Sahoo
Sujata Pradhan
Manisha Sahu
author_facet Pratyasha Peepal
Padmalaya Thakur
Anubhuti Patel
Jyotiranjan Sahoo
Sujata Pradhan
Manisha Sahu
author_sort Pratyasha Peepal
collection DOAJ
description Background: Conventionally, letrozole for ovulation induction (OI) in polycystic ovary syndrome (PCOS) is started at a dose of 2.5 mg, which is gradually escalated depending on the follicular response. The minimum dose required for follicular response for a particular patient is yet to be determined. Aim: The aim of the study was to compare various clinical and ultrasonographic characteristics of patients with successful OI with different doses of letrozole and individualise the dose of letrozole. Setting and Design: This prospective cohort study was conducted in a tertiary care teaching hospital from December 2019 to March 2024. Materials and Methods: Ninety-seven patients were treated with a starting dose of 2.5 mg of letrozole. The dose was increased to 5 and 7.5 mg without a follicular response. Various clinical and ultrasonographic characteristics were compared. Statistical Analysis Used: Data entered in Microsoft Excel and analysed using SPSS version 27. P < 0.05 was statistically significant. Results: Of 97 patients, 10 were lost to follow-up. Eighty-one (93.1%) patients had a positive response to letrozole. Six (6.9%) patients did not respond to the maximum dose of 7.5 mg of letrozole. Waist circumference, maximum antral follicle count per ovary and volume of the largest ovary were significantly different for patients who responded to different doses of letrozole (P < 0.05). Further analysis revealed that an ovarian volume of 10 cc or more is a risk factor for non-response to 2.5 mg of letrozole. Conclusion: The ovarian volume can be considered when determining the dose of letrozole in PCOS.
format Article
id doaj-art-f84e00c20cd04fe496cd91e1a3180b49
institution Matheson Library
issn 0974-1208
1998-4766
language English
publishDate 2025-04-01
publisher Wolters Kluwer Medknow Publications
record_format Article
series Journal of Human Reproductive Sciences
spelling doaj-art-f84e00c20cd04fe496cd91e1a3180b492025-07-04T08:45:57ZengWolters Kluwer Medknow PublicationsJournal of Human Reproductive Sciences0974-12081998-47662025-04-01182899510.4103/jhrs.jhrs_72_25Individualisation of the Dose of Letrozole for Ovulation Induction in Infertile Women with Polycystic Ovary Syndrome Based on Clinical and Ultrasonography Criteria: A Cohort StudyPratyasha PeepalPadmalaya ThakurAnubhuti PatelJyotiranjan SahooSujata PradhanManisha SahuBackground: Conventionally, letrozole for ovulation induction (OI) in polycystic ovary syndrome (PCOS) is started at a dose of 2.5 mg, which is gradually escalated depending on the follicular response. The minimum dose required for follicular response for a particular patient is yet to be determined. Aim: The aim of the study was to compare various clinical and ultrasonographic characteristics of patients with successful OI with different doses of letrozole and individualise the dose of letrozole. Setting and Design: This prospective cohort study was conducted in a tertiary care teaching hospital from December 2019 to March 2024. Materials and Methods: Ninety-seven patients were treated with a starting dose of 2.5 mg of letrozole. The dose was increased to 5 and 7.5 mg without a follicular response. Various clinical and ultrasonographic characteristics were compared. Statistical Analysis Used: Data entered in Microsoft Excel and analysed using SPSS version 27. P < 0.05 was statistically significant. Results: Of 97 patients, 10 were lost to follow-up. Eighty-one (93.1%) patients had a positive response to letrozole. Six (6.9%) patients did not respond to the maximum dose of 7.5 mg of letrozole. Waist circumference, maximum antral follicle count per ovary and volume of the largest ovary were significantly different for patients who responded to different doses of letrozole (P < 0.05). Further analysis revealed that an ovarian volume of 10 cc or more is a risk factor for non-response to 2.5 mg of letrozole. Conclusion: The ovarian volume can be considered when determining the dose of letrozole in PCOS.https://journals.lww.com/10.4103/jhrs.jhrs_72_25individualisationletrozoleovulation inductionpolycystic ovary syndromeultrasonography criteria
spellingShingle Pratyasha Peepal
Padmalaya Thakur
Anubhuti Patel
Jyotiranjan Sahoo
Sujata Pradhan
Manisha Sahu
Individualisation of the Dose of Letrozole for Ovulation Induction in Infertile Women with Polycystic Ovary Syndrome Based on Clinical and Ultrasonography Criteria: A Cohort Study
Journal of Human Reproductive Sciences
individualisation
letrozole
ovulation induction
polycystic ovary syndrome
ultrasonography criteria
title Individualisation of the Dose of Letrozole for Ovulation Induction in Infertile Women with Polycystic Ovary Syndrome Based on Clinical and Ultrasonography Criteria: A Cohort Study
title_full Individualisation of the Dose of Letrozole for Ovulation Induction in Infertile Women with Polycystic Ovary Syndrome Based on Clinical and Ultrasonography Criteria: A Cohort Study
title_fullStr Individualisation of the Dose of Letrozole for Ovulation Induction in Infertile Women with Polycystic Ovary Syndrome Based on Clinical and Ultrasonography Criteria: A Cohort Study
title_full_unstemmed Individualisation of the Dose of Letrozole for Ovulation Induction in Infertile Women with Polycystic Ovary Syndrome Based on Clinical and Ultrasonography Criteria: A Cohort Study
title_short Individualisation of the Dose of Letrozole for Ovulation Induction in Infertile Women with Polycystic Ovary Syndrome Based on Clinical and Ultrasonography Criteria: A Cohort Study
title_sort individualisation of the dose of letrozole for ovulation induction in infertile women with polycystic ovary syndrome based on clinical and ultrasonography criteria a cohort study
topic individualisation
letrozole
ovulation induction
polycystic ovary syndrome
ultrasonography criteria
url https://journals.lww.com/10.4103/jhrs.jhrs_72_25
work_keys_str_mv AT pratyashapeepal individualisationofthedoseofletrozoleforovulationinductionininfertilewomenwithpolycysticovarysyndromebasedonclinicalandultrasonographycriteriaacohortstudy
AT padmalayathakur individualisationofthedoseofletrozoleforovulationinductionininfertilewomenwithpolycysticovarysyndromebasedonclinicalandultrasonographycriteriaacohortstudy
AT anubhutipatel individualisationofthedoseofletrozoleforovulationinductionininfertilewomenwithpolycysticovarysyndromebasedonclinicalandultrasonographycriteriaacohortstudy
AT jyotiranjansahoo individualisationofthedoseofletrozoleforovulationinductionininfertilewomenwithpolycysticovarysyndromebasedonclinicalandultrasonographycriteriaacohortstudy
AT sujatapradhan individualisationofthedoseofletrozoleforovulationinductionininfertilewomenwithpolycysticovarysyndromebasedonclinicalandultrasonographycriteriaacohortstudy
AT manishasahu individualisationofthedoseofletrozoleforovulationinductionininfertilewomenwithpolycysticovarysyndromebasedonclinicalandultrasonographycriteriaacohortstudy